1.

Record Nr.

UNISA996384717603316

Autore

Partridge John <1644-1715.>

Titolo

Merlinus liberatus [[electronic resource] ] : being an almanack for the year of our redemption, 1692 and from the creation of the world according to the best of history, 5641 : it being the bissextile or leap year and the fourth also  of our deliverance from popery and arbitrary governement ... : to which is added ... J.G.'s verses about the Prince of Wales in his almanack 1689, travesty'd : calculated for ... London ...

Pubbl/distr/stampa

London, : Printed by R.R. the Company of Stationers, [1692]

Descrizione fisica

[47] p

Soggetti

Almanacs, English

Ephemerides

Astrology

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Reproduction of original in the Bodleian Library.

Sommario/riassunto

eebo-0014



2.

Record Nr.

UNINA9910768385603321

Titolo

Le management fantôme de la médecine : Les mains invisibles de Big Pharma

Pubbl/distr/stampa

Lyon, : ENS Éditions, 2023

ISBN

979-1-03-629170-8

9791036291706

Descrizione fisica

1 online resource (278 p.)

Collana

Gouvernement en question(s)

Soggetti

Pharmaceutical industries

Political science & theory

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Sommario/riassunto

While most actors in the drug production chain should operate under the label of science, their knowledge is in fact drawn from streams of knowledge that have been fed, spread and maintained by the pharmaceutical industry, in an intimate dialogue between science and marketing. Operating in the shadows, many "invisible hands" working for Big Pharma elaborate this knowledge: publication planners commission ghostwritten medical journal articles; key opinion leaders and sales representatives are recruited and deployed to subtly change doctors' behaviour; patient organisations, influenced by the industry, spread biased points of view on diseases and treatments. Ultimately, at the end of this ghostly production chain driven by this "assemblage marketing", prescriptions written by doctors will "naturally" make way for the new drugs promoted by pharmaceutical companies. Addressing a wide audience, Sergio Sismondo's aim, with this book of which we offer here a previously unpublished translation, is to lift the veil on the ghost management in the pharmaceutical industry, a management we should all be concerned about, given its major impact on public health.